Kestra Medical Technologies Logs Higher 3Q Revenue

Dow Jones

Apr 15

By Kelly Cloonan

Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public.

The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier.

Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago.

New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales.

For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

April 14, 2025 16:40 ET (20:40 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2527930144"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527930144\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527930144?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-15 04:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527930144","market":"nz","top_or_hot":-1,"title":"Kestra Medical Technologies Logs Higher 3Q Revenue","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public. \n</p>\n<p>\n  The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier. \n</p>\n<p>\n  Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago. \n</p>\n<p>\n  New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales. \n</p>\n<p>\n  For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 16:40 ET (20:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kestra Medical Technologies Logs Higher 3Q Revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKestra Medical Technologies Logs Higher 3Q Revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-15 04:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public. \n</p>\n<p>\n  The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier. \n</p>\n<p>\n  Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago. \n</p>\n<p>\n  New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales. \n</p>\n<p>\n  For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 16:40 ET (20:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KMTS","symbol_name":"Kestra Medical Technologies Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527930144","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527930144","pubTimestamp":1744663200,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public.The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier.Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago.New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales.For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"KMTS":"Kestra Medical Technologies Inc"},"translate_title":"Kestra Medical Technologies第三季度收入增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KMTS":0.9},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public. \n\n\n  The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier. \n\n\n  Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago. \n\n\n  New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales. \n\n\n  For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 16:40 ET (20:40 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}